Effects of time-variant exposure on toxic substance response.

por Morrison, P F
Publicado 1987

Insurance, genetic testing and familial cancer: recent policy changes in the United Kingdom.

por Morrison, P. J.
Publicado 2001

Accuracy of the clinical diagnosis of Down syndrome.

por Devlin, L., Morrison, P. J.
Publicado 2004

Stable Solitary Propagation Of Optical Beams

por Kurki-Suonio, T, Tajima, T, Morrison, P J
Publicado 1990

Huntington disease in County Donegal: epidemiological trends over four decades.

por Morrison, P. J., Nevin, N. C.
Publicado 1993

Cancer Genetics Services in Northern Ireland

por Morrison, P. J., Nevin, N. C.
Publicado 1999

Familial craniosynostosis due to Pro250Arg mutation in the fibroblast growth factor receptor 3 gene.

por Hughes, J., Nevin, N. C., Morrison, P. J.
Publicado 2001

Hereditary non-polyposis colon cancer.

por Devlin, L. A., Price, J. H., Morrison, P. J.
Publicado 2005

A Second Family with Probable CRAC (Colorectal Adenomata and Carcinoma) Syndrome—A New Familial Cancer

por Morrison, P. J., Chu, C. E., Nevin, N. C.
Publicado 1999

Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.

por Stuart-Harris, R., Bradbrook, I., Morrison, P., Smith, I. E., Rogers, H. J.
Publicado 1985

Thyroidectomy for medullary carcinoma in MEN 2A: positive genetic screening as the sole indicator for surgery.

por McNally, D., Campbell, W. J., Sloan, J. M., Morrison, P. J., Russell, C. F.
Publicado 1997

Intraspecific variation and plasticity in mitochondrial oxygen binding affinity as a response to environmental temperature

por Chung, Dillon J., Morrison, P. R., Bryant, H. J., Jung, E., Brauner, C. J., Schulte, P. M.
Publicado 2017

Validation of the i-STAT system for the analysis of blood gases and acid–base status in juvenile sandbar shark (Carcharhinus plumbeus)

por Harter, T. S., Morrison, P. R., Mandelman, J. W., Rummer, J. L., Farrell, A. P., Brill, R. W., Brauner, C. J.
Publicado 2015

Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up

por Foster, C, Watson, M, Eeles, R, Eccles, D, Ashley, S, Davidson, R, Mackay, J, Morrison, P J, Hopwood, P, Evans, D G R
Publicado 2007

Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort

por Foster, C, Evans, D G R, Eeles, R, Eccles, D, Ashley, S, Brooks, L, Davidson, R, Mackay, J, Morrison, P J, Watson, M
Publicado 2002

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort

por Watson, M, Foster, C, Eeles, R, Eccles, D, Ashley, S, Davidson, R, Mackay, J, Morrison, P J, Hopwood, P, Evans, D G R
Publicado 2004

Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type

por Perkins, A M, Ettinger, U, Weaver, K, Schmechtig, A, Schrantee, A, Morrison, P D, Sapara, A, Kumari, V, Williams, S C R, Corr, P J
Publicado 2013

Cancer Genetics Services in Europe

por Hodgson, S., Milner, B., Brown, I., Bevilacqua, G., Chang-Claude, J., Eccles, D., Evans, G., Gregory, H., Møller, P., Morrison, P., Steel, M., Stoppa-Lyonnet, D., Vasen, H., Haites, N.
Publicado 1999

Utilisation of Prophylactic Mastectomy in 10 European Centres

por Evans, D. G. R., Anderson, E., Lalloo, F., Vasen, H., Beckmann, M., Eccles, D., Hodgson, S., Møller, P., Chang-Claude, J., Morrison, P., Stoppa-Lyonnet, D., Steel, M., Haites, N.
Publicado 1999

Genetic Testing for Breast Cancer Predisposition in 1999: Which Molecular Strategy and which Family Criteria?

por Stoppa-Lyonnet, D., Caligo, M., Eccles, D., Evans, D. G. R., Haites, N. E., Hodgson, N. S., Møller, P., Morrison, P. J., Steel, C. M., Vasen, H. F. A., Chang-Claude, J.
Publicado 1999